Dengue Seroprevalence Study in Blood Donors in the French West Indies (DengSeroprevAn)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01104740 |
Recruitment Status
: Unknown
Verified April 2010 by Etablissement Français du Sang, Martinique.
Recruitment status was: Not yet recruiting
First Posted
: April 15, 2010
Last Update Posted
: April 15, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Blood Donors Dengue | Other: Biological sample collection |
-
Principal objective:
To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood donors in the French West Indies.
- Secondary objective:
To specify the serotypic specificity of the anti-dengue antibodies detected during the study.
Study Type : | Observational |
Estimated Enrollment : | 770 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Dengue Seroprevalence Study in Blood Donors in the French West Indies |
Study Start Date : | June 2010 |
Estimated Primary Completion Date : | June 2010 |
Estimated Study Completion Date : | June 2010 |

-
Other: Biological sample collection
- Presence or not of dengue virus-specific immunoglobulin G antibodies [ Time Frame: 1 day ]
- Characterization of dengue virus serotype-specific IgG [ Time Frame: 1 day ]Characterization of dengue virus serotype-psecific IgG whendengue virus serotype-specific immunoglobulin G antibodies Test is positive
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 65 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Eligible for blood donation following the French legislation,
- Resident in Martinique /Guadeloupe for at least one year
- Consent signed
Exclusion Criteria:
- Not Eligible for blood donation following the French legislation,
- Not Resident in Martinique / Guadeloupe for at least one year
- Consent not signed

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01104740
Contact: Janick JEAN-MARIE, Master | 592697 ext 33596 | janick.jean-marie@chu-fortdefrance.fr | |
Contact: Paul Mourlhou | 592697 ext 33596 | paul.mourlhou@chu-fortdefrance.fr |
Guadeloupe | |
French Blood Establishment of Guadeloupe | Not yet recruiting |
Pointe-à-Pitre, Guadeloupe, 97171 | |
Contact: Rémi Courbil, Ph.D 891555 ext 33590 remi.courbil@efs.sante.fr | |
Principal Investigator: Rémi Courbil, Ph.D | |
Martinique | |
French Blood Establishment of Martinique | Not yet recruiting |
Fort-de-France, Martinique, 97264 | |
Contact: Pascale Richard, MD 757915 ext 33596 pascale.richard@efs.sante.fr | |
Principal Investigator: Pascale Richard, MD |
Principal Investigator: | Pascale RICHARD, MD | French Blood Establishment of Martinique |
Responsible Party: | RICHARD / Chef Executive Officer, Etablissement Français du sang de Martinique |
ClinicalTrials.gov Identifier: | NCT01104740 History of Changes |
Other Study ID Numbers: |
10/B/01 |
First Posted: | April 15, 2010 Key Record Dates |
Last Update Posted: | April 15, 2010 |
Last Verified: | April 2010 |
Additional relevant MeSH terms:
Dengue Arbovirus Infections Virus Diseases Flavivirus Infections |
Flaviviridae Infections RNA Virus Infections Hemorrhagic Fevers, Viral |